Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FAG89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,798
Award facts
- Contract value 100% obligated
- $8,798.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,798.43 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count packaging) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location.
This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor IDC with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. Vraylar is a neurological treatment medication supplied as part of AmerisourceBergen's extensive portfolio supporting federal medical procurement, particularly for military and veteran healthcare systems. The contract reflects the company's capability to deliver specialized pharmaceutical products through open competition and supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB26FAG89?
SPE2DB26FAG89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FAG89 worth?
The government has obligated $8,798 on SPE2DB26FAG89.
Is contract SPE2DB26FAG89 an order under another contract?
Yes. SPE2DB26FAG89 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB26FAG89 competed?
The extent of competition for SPE2DB26FAG89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award